- Report
- July 2023
- 89 Pages
Middle East
From €3045EUR$3,400USD£2,596GBP
€3583EUR$4,000USD£3,054GBP
- Report
- February 2024
- 110 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- February 2024
- 90 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- April 2023
- 105 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- April 2023
- 112 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- January 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- May 2024
- 200 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- February 2024
- 61 Pages
From €3090EUR$3,450USD£2,634GBP
- Report
- February 2024
- 78 Pages
Asia Pacific
From €3090EUR$3,450USD£2,634GBP
- Report
- September 2022
- 152 Pages
From €3090EUR$3,450USD£2,634GBP
- Report
- August 2023
- 80 Pages
United Kingdom
From €1344EUR$1,500USD£1,145GBP
From €1344EUR$1,500USD£1,145GBP
- Report
- August 2023
- 80 Pages
South Korea
From €1344EUR$1,500USD£1,145GBP
- Report
- August 2023
- 80 Pages
Saudi Arabia
From €1344EUR$1,500USD£1,145GBP
- Report
- August 2023
- 80 Pages
India
From €1344EUR$1,500USD£1,145GBP
- Report
- August 2023
- 80 Pages
Germany
From €1344EUR$1,500USD£1,145GBP
- Report
- August 2023
- 80 Pages
France
From €1344EUR$1,500USD£1,145GBP
- Report
- August 2023
- 80 Pages
China
From €1344EUR$1,500USD£1,145GBP
- Report
- August 2023
- 300 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- May 2022
- 324 Pages
Global
From €3224EUR$3,600USD£2,749GBP
The genotyping market is a subset of the genomics industry that focuses on the identification of genetic variations between individuals. It is used to identify genetic markers associated with diseases, to determine the risk of developing certain conditions, and to identify the most effective treatments for a given individual. Genotyping is also used in the development of personalized medicine, which is tailored to the individual’s genetic makeup. Genotyping technologies include next-generation sequencing, microarrays, and PCR-based methods.
The genotyping market is expected to grow due to the increasing demand for personalized medicine, the development of new technologies, and the increasing availability of genomic data. Additionally, the increasing prevalence of chronic diseases and the need for more accurate diagnosis and treatment are expected to drive the growth of the genotyping market.
Some companies in the genotyping market include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and PerkinElmer. Show Less Read more
